Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A+C meningococcal–Hib conjugate combined vaccine in infants and young children
CTR20191736Phase 3Completed
- Sponsor
- Olin Biological
- Start
- Oct 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of group A and C meningococcal + Haemophilus influenzae type b conjugate combined vaccine in meningococcal meningitis, Haemophilus influenzae type b disease (Hib), sponsored by Olin Biological. Started Oct 2019; status: completed.
02
Drugs
group A and C meningococcal + Haemophilus influenzae type b conjugate combined vaccine
03
Conditions
meningococcal meningitisHaemophilus influenzae type b disease (Hib)
Beyond the preview
Go deeper on CTR20191736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20191736.